Honglei Luo

Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial

Qi Liu, Junqiang Chen, Lin Yu et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 77 citations

Medicine, Oncology, Surgical Oncology +8

Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation

Hongfang Zhang, Honglei Luo, Zhaoyang Hu et al. · Oncotarget · 2015 · 57 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial

Congying Xie, Jing Zhao, Honglei Luo et al. · British Journal of Cancer · 2020 · 29 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer

Shixiu Wu, Lvhua Wang, Honglei Luo et al. · European Journal of Cancer · 2018 · 28 citations

Medicine, Oncology, Radiation Oncology +15

Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma

Honglei Luo, Wei Jiang, Li Ma et al. · JAMA Network Open · 2020 · 25 citations · Full text

Medicine, Oncology, Radiation Oncology +15